Merchant & Gould, a leading national IP law firm, today announced that Gary M. Myles, Ph.D., has joined its Seattle office as Of Counsel. Myles focuses his practice on biotechnology and medical device patent strategy, prosecution and licensing.
"Gary is a welcome addition to our firm and to our life sciences practice group," said Brian Batzli, CEO and managing director of Merchant & Gould. "His rich background in patent law and bioscience research ensure that he will contribute immediately to this firm and our clients."
Since 2002, Dr. Myles has been an adjunct professor and Law, Technology & Arts Fellow with the University of Washington School of Law, where he teaches Advanced Patent Law. He is frequently published in scientific journals and regularly presents CLE courses relating to biotechnology. Myles has been named by Washington Super Lawyers as one of the top attorneys in the state in both 2010 and 2011. Each year, no more than five percent of the lawyers in the state receive this honor.
Myles received his J.D. from the University of Washington School of Law, and his Ph.D. in biochemistry and biophysics from the University of North Carolina, Chapel Hill. Most recently he was a shareholder with Shwabe, Williamson & Wyatt in Seattle.